[Federal Register Volume 87, Number 35 (Tuesday, February 22, 2022)]
[Notices]
[Page 9622]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03629]



[[Page 9622]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Award of a Single-Source Cooperative Agreement To Fund 
the Kazakhstan Scientific Center for Dermatology and Infectious 
Diseases (KSCDID)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), located 
within the Department of Health and Human Services (HHS), announces the 
award of approximately $500,000, for Year 1 of funding to the 
Kazakhstan Scientific Center for Dermatology and Infectious Diseases 
(KSCDID). The award will reduce new HIV infections and AIDS deaths in 
Kazakhstan through rapidly expanding prevention, testing, care, and 
effective treatment services to people living with HIV (PLHIV). Funding 
amounts for years 2-5 will be set at continuation.

DATES: The period for this award will be September 30, 2022 through 
September 29, 2027.

FOR FURTHER INFORMATION CONTACT: Patrick Nadol, Center for Global 
Health, Centers for Disease Control and Prevention, 171 Prospect Mira, 
Bishkek, 720016, Kyrgyz Republic, Telephone: 800-232-6348, E-Mail: 
<a href="/cdn-cgi/l/email-protection#6c1c0902592c0f080f420b031a"><span class="__cf_email__" data-cfemail="cfbfaaa1fa8facabace1a8a0b9">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: The single-source award will implement 
prevention, testing, care and treatment, laboratory, and strategic 
information activities in Kazakhstan. KSCDID is in a unique position to 
conduct this work, as it is the leading organization implementing the 
National HIV program in Kazakhstan; it will lead and sustain the 
national HIV services for prevention, testing, care, treatment, and 
strategic information according to international standards to achieve 
epidemic control and ensure resilient and sustained health care 
systems. KSCDID develops policy and regulations, conducts prevention 
and testing activities, coordinates care and treatment, and is 
responsible for quality assurance of laboratory services.

Summary of the Award

    Recipient: Kazakhstan Scientific Center for Dermatology and 
Infectious Diseases (KSCDID).
    Purpose of the Award: The purpose of this award is to reduce new 
HIV infections and AIDS deaths in Kazakhstan through rapidly expanding 
prevention, testing, care, and effective treatment services to PLHIV.
    Amount of Award: The approximate year 1 funding amount will be 
$500,000 in Federal Fiscal Year (FFY) 2022 funds, subject to the 
availability of funds. Funding amounts for years 2-5 will be set at 
continuation.
    Authority: This program is authorized under Public Law 108-25 (the 
United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act 
of 2003).
    Period of Performance: September 30, 2022 through September 29, 
2027.

    Dated: February 15, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-03629 Filed 2-18-22; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>